ConductScience.org, home

Paper36770334

Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo.

Markelić M and 8 others. Nanomaterials (Basel), 2023. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo. Papers, record 36770334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36770334

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application In Vivo.
PubMed
Journal
Nanomaterials (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.14
iCite
Revised in PubMed
2024-09-12
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Markelić MMilicahttps://orcid.org/0000-0002-5444-7735
2Mojić MMarijahttps://orcid.org/0000-0002-4906-9880
3Bovan DDijana
4Jelača SSanjahttps://orcid.org/0000-0002-9848-6859
5Jović ZZorana
6Purić MMilica
7Koruga DDjuro
8Mijatović SSanja
9Maksimović-Ivanić DDanijelahttps://orcid.org/0000-0002-8006-5079

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
451-03-68/2022-14/200007Ministry of Education, Science and Technological Development of the Republic of SerbiaPubMed
20/02847Zepter InternationalPubMed

Source PubMed

Download CSV of grants

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132036302Advances in nanomaterials for photodynamic therapy applications: Status and challenges.Biomaterials2020https://conductscience.org/library/papers/32036302PubMed
235262820Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8+ T-cell mediated cytotoxicity in colorectal cancer.Mol Biol Rep2022https://conductscience.org/library/papers/35262820PubMed
333806466In Vivo Quantitative Vasculature Segmentation and Assessment for Photodynamic Therapy Process Monitoring Using Photoacoustic Microscopy.Sensors (Basel)2021https://conductscience.org/library/papers/33806466PubMed
416794636Photodynamic therapy and anti-tumour immunity.Nat Rev Cancer2006https://conductscience.org/library/papers/16794636PubMed
531472877Chitosan-coated liposomes to stabilize and enhance transdermal delivery of indocyanine green for photodynamic therapy of melanoma.Carbohydr Polym2019https://conductscience.org/library/papers/31472877PubMed
630832998Intralesional Cancer Immunotherapies.Hematol Oncol Clin North Am2019https://conductscience.org/library/papers/30832998PubMed
733262144Senescence and the SASP: many therapeutic avenues.Genes Dev2020https://conductscience.org/library/papers/33262144PubMed
832630174Reactive Oxygen Species and Antitumor Immunity-From Surveillance to Evasion.Cancers (Basel)2020https://conductscience.org/library/papers/32630174PubMed
927364482A fate worse than death: apoptosis as an oncogenic process.Nat Rev Cancer2016https://conductscience.org/library/papers/27364482PubMed
1033613512Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.Front Immunol2020https://conductscience.org/library/papers/33613512PubMed
1124278043Skin melanocytes: biology and development.Postepy Dermatol Alergol2013https://conductscience.org/library/papers/24278043PubMed
1220078217The senescence-associated secretory phenotype: the dark side of tumor suppression.Annu Rev Pathol2010https://conductscience.org/library/papers/20078217PubMed
1331675495Cellular Senescence: Defining a Path Forward.Cell2019https://conductscience.org/library/papers/31675495PubMed
1417878918Melanosomes--dark organelles enlighten endosomal membrane transport.Nat Rev Mol Cell Biol2007https://conductscience.org/library/papers/17878918PubMed
1519704071Influence of melanosome dynamics on melanoma drug sensitivity.J Natl Cancer Inst2009https://conductscience.org/library/papers/19704071PubMed
1631181772The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology.Int J Mol Sci2019https://conductscience.org/library/papers/31181772PubMed
1731235879Unmasking senescence: context-dependent effects of SASP in cancer.Nat Rev Cancer2019https://conductscience.org/library/papers/31235879PubMed
1830573629NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination.Science2018https://conductscience.org/library/papers/30573629PubMed
1929477613Hallmarks of Cellular Senescence.Trends Cell Biol2018https://conductscience.org/library/papers/29477613PubMed
2027141342CD8 engineered cytotoxic T cells reprogram melanoma tumor environment.Oncoimmunology2016https://conductscience.org/library/papers/27141342PubMed

See all 65 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41623512Effects of Light-Induced Electromagnetic Fields on Human Cancer Cells in Vitro.Bioelectricity2025https://conductscience.org/library/papers/41623512PubMed
40731679Molecular "Yin-Yang" Machinery of Synthesis of the Second and Third Fullerene C60 Derivatives.Micromachines (Basel)2025https://conductscience.org/library/papers/40731679PubMed
39598477Effect of Particle Size on Physical Properties, Dissolution, In Vitro Antioxidant Activity, and In Vivo Hepatoprotective Properties of Tetrastigma hemsleyanum Diels et Gilg Powders.Pharmaceutics2024https://conductscience.org/library/papers/39598477PubMed
38470808Comparative Studies of the Structural and Physicochemical Properties of the First Fullerene Derivative FD-C60 (Fullerenol) and Second Fullerene Derivate SD-C60 (3HFWC).Nanomaterials (Basel)2024https://conductscience.org/library/papers/38470808PubMed
38138321The Second Derivative of Fullerene C60 (SD-C60) and Biomolecular Machinery of Hydrogen Bonds: Water-Based Nanomedicine.Micromachines (Basel)2023https://conductscience.org/library/papers/38138321PubMed
37049247Editorial for Special Issue "Cancer Treatment via Nanotherapy".Nanomaterials (Basel)2023https://conductscience.org/library/papers/37049247PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36770334

GET https://conductscience.org/api/papers/v1/36770334/references?page=2